SOPHARMA AD - DISCLOSURE OF SHAREHOLDINGS

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 32 / 2012

Date of issue: 2012-04-18

Short name of the issuer

SOPHARMA AD

Subject

DISCLOSURE OF SHAREHOLDINGS

Official market - legal basis

Inne uregulowania

Unofficial market - legal basis

Contents of the report:

The Board of Directors of Sopharma AD (the “Company") announces that it has received notifications of disclosure of shareholdings under Art. 145 of POSA: Gramercy Select Master Fund, USA, Georgetown sold 8,587,285 shares, representing 6.51% of the capital of Sopharma, thereby closing its position in the capital of "Sopharma" AD, and Gramercy Emerging Markets Fund, USA, Georgetown sold 7,980,192 shares, representing 6.05% of the capital of Sopharma, thereby closing its position in the capital of "Sopharma" AD. The date of registration of the two transactions with the Central Depository is April 9, 2012.

Annexes

File Description

Current report 32 d_uchastie_Gramercy_18042012 ЕNG.doc Current report 32

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2012-04-18 Ognian Ivanov Donev Executive Director